Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Mazzucchelli

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Urology|August 4, 2012
Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinomaKatherine E Watts, Rodolfo Montironi, Roberta Mazzucchelli, et al.
Future Oncology (London, England)|April 27, 2016
Immunotargeting and personalized therapies in genitourinary cancersRoberta Mazzucchelli, Silvia Gasparrini, Andrea B Galosi, et al.
Human Pathology|October 17, 2003
Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinomaRodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
Diagnostic Pathology|July 4, 2013
Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinomaAntonio Zizzi, Maria Alessandra Montironi, Roberta Mazzucchelli, et al.
Clinical Genitourinary Cancer|March 10, 2020
Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily PracticeSara Cecchini, Daniele Castellani, Paolo Fabbietti, et al.
Future Oncology (London, England)|January 10, 2020
Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapyAlessia Cimadamore, Antonio Lopez-Beltran, Francesco Massari, et al.
BJU International|March 6, 2010
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancerDoriana Morichetti, Roberta Mazzucchelli, Daniela Stramazzotti, et al.
Urology|June 9, 2009
Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancerRoberta Mazzucchelli, Francesca Barbisan, Alfredo Santinelli, et al.
Human Pathology|February 26, 2014
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sectionsPaolo Castellini, Maria A Montironi, Antonio Zizzi, et al.
Cells|December 16, 2020
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsGaetano Aurilio, Alessia Cimadamore, Roberta Mazzucchelli, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Urology|August 4, 2012
Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinomaKatherine E Watts, Rodolfo Montironi, Roberta Mazzucchelli, et al.
Future Oncology (London, England)|April 27, 2016
Immunotargeting and personalized therapies in genitourinary cancersRoberta Mazzucchelli, Silvia Gasparrini, Andrea B Galosi, et al.
Human Pathology|October 17, 2003
Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinomaRodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
Diagnostic Pathology|July 4, 2013
Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinomaAntonio Zizzi, Maria Alessandra Montironi, Roberta Mazzucchelli, et al.
Clinical Genitourinary Cancer|March 10, 2020
Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily PracticeSara Cecchini, Daniele Castellani, Paolo Fabbietti, et al.
Future Oncology (London, England)|January 10, 2020
Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapyAlessia Cimadamore, Antonio Lopez-Beltran, Francesco Massari, et al.
BJU International|March 6, 2010
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancerDoriana Morichetti, Roberta Mazzucchelli, Daniela Stramazzotti, et al.
Urology|June 9, 2009
Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancerRoberta Mazzucchelli, Francesca Barbisan, Alfredo Santinelli, et al.
Human Pathology|February 26, 2014
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sectionsPaolo Castellini, Maria A Montironi, Antonio Zizzi, et al.
Cells|December 16, 2020
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsGaetano Aurilio, Alessia Cimadamore, Roberta Mazzucchelli, et al.
Pageof 18